HIGH-DOSE CYCLOPHOSPHAMIDE - AN EFFECTIVE TREATMENT FOR ADVANCED REFRACTORY MULTIPLE-MYELOMA

被引：0
|
作者：
LENHARD, RE
OKEN, MM
BARNES, JM
HUMPHREY, RL
GLICK, JH
SILVERSTEIN, MN
机构：
[1] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
[2] SIDNEY FARBER CANC INST,BOSTON,MA 02115
[3] UNIV PENN,PHILADELPHIA,PA 19104
[4] MAYO CLIN,ROCHESTER,MN
来源：
CANCER | 1984年 / 53卷 / 07期
关键词：
D O I：
10.1002/1097-0142(19840401)53:7<1456::AID-CNCR2820530705>3.0.CO;2-C
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1456 / 1460
页数：5
相关论文
共 50 条
  • [31] High-Dose Cyclophosphamide in the Treatment of Multiple Sclerosis
    Schwartzman, Robert Jay
    Simpkins, Nicole
    Alexander, Guillermo M.
    Reichenberger, Erin
    Ward, Kristine
    Lindenberg, Noah
    Topolsky, David
    Crilley, Pam
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2009, 15 (02) : 118 - 127
  • [32] Effective mobilization of stem cells in multiple myeloma following priming by high-dose cyclophosphamide and bortezomib
    Reti, M.
    Mikala, G.
    Goda, V.
    Janosi, J.
    Peto, M.
    Masszi, T.
    [J]. BLOOD REVIEWS, 2007, 21 : S90 - S90
  • [33] HIGH-DOSE MELPHALAN AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR REFRACTORY MULTIPLE-MYELOMA
    BARLOGIE, B
    JAGANNATH, S
    DIXON, DO
    CHESON, B
    SMALLWOOD, L
    HENDRICKSON, A
    PURVIS, JD
    BONNEM, E
    ALEXANIAN, R
    [J]. BLOOD, 1990, 76 (04) : 677 - 680
  • [34] HIGH-DOSE THERAPY FOR REFRACTORY MULTIPLE-MYELOMA - IMPROVED PROGNOSIS WITH BETTER SUPPORTIVE CARE AND DOUBLE TRANSPLANTS
    VESOLE, DH
    BARLOGIE, B
    JAGANNATH, S
    CHESON, B
    TRICOT, G
    ALEXANIAN, R
    CROWLEY, J
    [J]. BLOOD, 1994, 84 (03) : 950 - 956
  • [35] HEXAMETHYLMELAMINE (HMM) - NEW AGENT EFFECTIVE IN TREATMENT OF REFRACTORY MULTIPLE-MYELOMA
    COHEN, HJ
    [J]. BLOOD, 1977, 50 (05) : 187 - 187
  • [36] High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
    Gladstone, Douglas E.
    Zamkoff, Kenneth W.
    Krupp, Lauren
    Peyster, Robert
    Sibony, Patrick
    Christodoulou, Christopher
    Locher, Emily
    Coyle, Patricia K.
    [J]. ARCHIVES OF NEUROLOGY, 2006, 63 (10) : 1388 - 1393
  • [37] INFUSED VINCRISTINE AND ADRIAMYCIN WITH HIGH-DOSE METHYLPREDNISOLONE (VAMP) IN ADVANCED PREVIOUSLY TREATED MULTIPLE-MYELOMA PATIENTS
    FORGESON, GV
    SELBY, P
    LAKHANI, S
    ZULIAN, G
    VINER, C
    MAITLAND, J
    MCELWAIN, TJ
    [J]. BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 469 - 473
  • [38] IDIOTYPIC IMMUNOGLOBULIN AS AN INDICATOR OF RESIDUAL DISEASE IN MULTIPLE-MYELOMA FOLLOWING TREATMENT WITH HIGH-DOSE MELPHALAN
    THOMPSON, J
    SELBY, P
    ANDERSON, V
    MCELWAIN, TJ
    STEVENSON, GT
    [J]. BRITISH JOURNAL OF CANCER, 1987, 55 (03) : 345 - 345
  • [39] SAFE AND EFFECTIVE MOBILIZATION OF STEM CELLS IN MULTIPLE MYELOMA FOLLOWING PRIMING BY HIGH-DOSE CYCLOPHOSPHAMIDE AND BORTEZOMIB
    Mikala, G.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 263 - 263
  • [40] INTERMITTENT HIGH-DOSE MELPHALAN PREDNISONE VS CONTINUOUS LOW-DOSE MELPHALAN TREATMENT IN MULTIPLE-MYELOMA
    AHRE, A
    BJORKHOLM, M
    MELLSTEDT, H
    HOLM, G
    BRENNING, G
    ENGSTEDT, L
    GAHRTON, G
    HALLEN, J
    JOHANSSON, B
    JOHANSSON, SGO
    KARNSTROM, L
    KILLANDER, A
    LERNER, R
    LOCKNER, D
    LONNQVIST, B
    SIMONSSON, B
    STALFELT, AM
    TERNSTEDT, B
    WADMAN, B
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (04): : 499 - 506
12345